Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/48955

TitleHPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?
Author(s)Costa, Allini Mafra da
Fregnani, José Humberto Tavares Guerreiro
Pastrez, Paula Roberta Aguiar
Mariano, Vânia Sammartino
Silva, Estela Maria
Scapulatempo-Neto, Cristovam
Guimarães, Denise Peixoto
Villa, Luisa Lina
Sichero, Laura
Syrjanen, Kari
Longatto Filho, Adhemar
KeywordsHuman Papillomavirus
Esophageal cancer
Survival
Issue date2017
PublisherBioMed Central (BMC)
JournalInfectious Agents and Cancer
Abstract(s)Background: Esophageal squamous cell carcinoma (ESCC) is a highly lethal malignant tumor. Currently, Human papillomavirus (HPV) is suggested as a potential risk factor for esophageal cancer (EC) in addition to the classic risk factors, alcohol and tobacco, but this hypothesis still remains contradictory. We sought to investigate wether HPV and well-known biomarkers (p16 and p53) and patient-related factors that may have impact on survival of ESCC. Methods: We conducted a prospective cohort study. By using multiplex PCR, we determined the prevalence of high risk HPV in ESCC, and evaluated the immunohistochemical expression of p16 and p53, molecular markers related to esophageal carcinogenesis in order to verify the potential influence of these variables in patients's survival. Survival rates were estimated using Kaplan-Meier methods. A multivariate confirmatory model was performed using Cox proportional hazards regression. Results: Twelve (13.8%) of 87 patients were HPV-DNA positive. Positive reactions of p16 and p53 were 10.7% and 68.6%, respectively. Kaplan-Meier analysis indicated that men (p = 0.025) had poor specific-cancer survival and a shorter progression-free survival (p = 0.050) as compared to women; III or IV clinical stage (p < 0.019) had poor specific-cancer survival and a shorter progression-free survival (p < 0.001) compared to I and II clinical stage; not submitted to surgery (< 0.001) and not submitted to chemoradiotherapy (p = 0.039) had a poor specific-cancer survival, as well. The multivariate analysis showed that HPV, p16 and p53 status are not predictive parameters of progression-free and specific-cancer survival. Conclusion: HPV infection and p53 and p16 expression are not prognostic factors in ESCC.
TypeArticle
URIhttp://hdl.handle.net/1822/48955
DOI10.1186/s13027-017-0163-4
ISSN1750-9378
Publisher versionhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640908/
Peer-Reviewedyes
AccessOpen access
Appears in Collections:ICVS - Artigos em Revistas Internacionais com Referee

Files in This Item:
File Description SizeFormat 
86.pdf490,28 kBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID